Ironwood Pharmaceuticals Inc. (IRWD) Reports In-Line Q3 EPS Loss of $0.21

Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) reported Q3 EPS of ($0.21), in-line with the analyst estimate of ($0.21). Revenue for the quarter came in at $12.22 million versus the consensus estimate of $12.92 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue